Ceapro will apply its patented extraction and processing technologies to create products with cosmeceutical, nutraceutical and pharmaceutical applications.
Mark Redmond, Ceapro’s CEO, said: “We expect our growing distributor network will find broad market appeal and acceptance for a rosmarinic acid that is odourless, tasteless and ingestible. This moves Ceapro’s natural product offerings beyond organics and into nutraceuticals.”